PharmaRadar360

PharmaRadar360

🇪🇺·1d agoResearchTier 2 · Direct publisher

Rare disease clinical trials in Italy (2022–May 2026): current trends, future challenges, and the evolving role as reporting member state

Publisher

E
Europe PMC

EU

This page provides publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.

Read original

At a glance

Publisher
Europe PMC
Region
EU
Scope
Research
Published
September 29, 2026
Language
EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on europepmc.org

Leave the platform to read the original full article on the publisher site.

Source: Europe PMC

Scope: Research

Evidence: Tier 2 · Direct publisher

Open original article
Rare disease clinical trials in Italy (2022–May 2026): current trends, future challenges, and the evolving role as reporting member state | PharmaRadar360